Chargement en cours...
Combination Therapies in Advanced, Hormone Receptor–Positive Breast Cancer
About 17% of women with breast cancer have locally advanced or metastatic disease at the time of diagnosis, and 30% to 40% of women diagnosed with early-stage disease will eventually have recurrence. The majority of breast cancers express estrogen or progesterone receptors, and hormonal therapies (H...
Enregistré dans:
| Publié dans: | J Adv Pract Oncol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Harborside Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296414/ https://ncbi.nlm.nih.gov/pubmed/30564467 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|